| Dr Christina Marie Flannelly, MD | |
|
8300 Health Park Ste 213, Raleigh, NC 27615-4731 | |
| (919) 896-7066 | |
| (919) 896-7067 |
| Full Name | Dr Christina Marie Flannelly |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 8300 Health Park Ste 213, Raleigh, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003866211 | NPI | - | NPPES |
| 8932454 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 39940 (North Carolina) | Primary |
| Entity Name | Raleigh Durham Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194828145 PECOS PAC ID: 2365409588 Enrollment ID: O20041220000155 |
News Archive
Cell Therapeutics, Inc. ("CTI") announced today that the European Medicines Agency ("EMA") approved CTI's Pixuvri (pixantrone dimaleate) Pediatric Investigation Plan ("PIP") for the treatment of lymphoid malignancies and solid tumors in children between the ages of six months and 18 years. Previously, the Pediatric Committee (the "PDCO") of the EMA adopted an opinion agreeing to the PIP and a deferral of the initiation of the clinical studies until after the drug receives EMA approval.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as "aggregate spend" reporting regulations.
TVG is pleased to welcome leading biotech and pharma executives at the 18th Annual BioPartnering Europe, held in London, UK. To open the conference, Dr. Anders Ekblom, Executive Vice President, Global Medicines Development at AstraZeneca, spoke about a commitment to innovation and AstraZeneca's unique approach to collaborations.
A large national study of dentists conducted by the National Dental Practice-Based Research Network has found that only 47 percent of dentists always use a dental dam during root canal treatment, with an additional 17 percent using it 90-99 percent of the time, according to a recent scientific publication in BMJ Open.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christina Marie Flannelly, MD 5420 Wade Park Blvd Ste 106, Raleigh, NC 27607-4189 Ph: (919) 233-5952 | Dr Christina Marie Flannelly, MD 8300 Health Park Ste 213, Raleigh, NC 27615-4731 Ph: (919) 896-7066 |
News Archive
Cell Therapeutics, Inc. ("CTI") announced today that the European Medicines Agency ("EMA") approved CTI's Pixuvri (pixantrone dimaleate) Pediatric Investigation Plan ("PIP") for the treatment of lymphoid malignancies and solid tumors in children between the ages of six months and 18 years. Previously, the Pediatric Committee (the "PDCO") of the EMA adopted an opinion agreeing to the PIP and a deferral of the initiation of the clinical studies until after the drug receives EMA approval.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as "aggregate spend" reporting regulations.
TVG is pleased to welcome leading biotech and pharma executives at the 18th Annual BioPartnering Europe, held in London, UK. To open the conference, Dr. Anders Ekblom, Executive Vice President, Global Medicines Development at AstraZeneca, spoke about a commitment to innovation and AstraZeneca's unique approach to collaborations.
A large national study of dentists conducted by the National Dental Practice-Based Research Network has found that only 47 percent of dentists always use a dental dam during root canal treatment, with an additional 17 percent using it 90-99 percent of the time, according to a recent scientific publication in BMJ Open.
› Verified 5 days ago
Sarah Owrey, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2800 Blue Ridge Rd, Suite 401, Raleigh, NC 27607 Phone: 919-781-7490 | |
Robert C Helms, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1921 Falls Valley Drive, Raleigh, NC 27615 Phone: 919-872-0250 Fax: 919-848-3137 | |
Jeff Lawrence Kantor, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 23 Sunnybrook Rd, Raleigh, NC 27610 Phone: 919-235-6435 | |
Dr. Delouis Terlonge Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3801 Computer Dr, Suite 200, Raleigh, NC 27609 Phone: 919-782-5273 Fax: 919-232-5551 | |
Larissa M. Saldana, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4551 New Bern Ave, Suite 160, Raleigh, NC 27610 Phone: 919-861-7793 Fax: 919-488-1458 | |
Dr. Bridget Mcnamara Degele, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2406 Blue Ridge Rd, Suite 100, Raleigh, NC 27607 Phone: 919-786-5001 Fax: 919-786-5051 |